Harvard Bioscience (HBIO) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -282.67% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 9.23% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 56.71% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 25.41% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 20.94% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -96.77% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -7.50% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | 93.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.19% |
| Dec 31, 2025 | -18,988.89% |
| Sep 30, 2025 | 74.36% |
| Jun 30, 2025 | 20.76% |
| Mar 31, 2025 | -971.45% |
| Dec 31, 2024 | 101.13% |
| Sep 30, 2024 | -287.57% |
| Jun 30, 2024 | -193.88% |
| Mar 31, 2024 | -854.66% |
| Dec 31, 2023 | 26.52% |
| Sep 30, 2023 | 63.61% |
| Jun 30, 2023 | -140.25% |
| Mar 31, 2023 | 108.99% |
| Dec 31, 2022 | -466.78% |
| Sep 30, 2022 | -1,902.94% |
| Jun 30, 2022 | 663.66% |
| Mar 31, 2022 | -934.08% |
| Dec 31, 2021 | 183.22% |
| Sep 30, 2021 | 84.75% |
| Jun 30, 2021 | 72.68% |
| Mar 31, 2021 | 85.19% |
| Dec 31, 2020 | -228.91% |
| Dec 31, 2019 | 224.15% |
| Dec 31, 2018 | -143.86% |
| Jun 30, 2018 | -85.59% |
| Mar 31, 2018 | 652.94% |
| Dec 31, 2017 | 176.52% |
| Sep 30, 2017 | 113.92% |
| Jun 30, 2017 | 133.10% |
| Mar 31, 2017 | 49.21% |
| Dec 31, 2016 | 92.30% |
| Sep 30, 2016 | -93.39% |
| Jun 30, 2016 | -304.30% |
| Mar 31, 2016 | 54.60% |
| Dec 31, 2013 | 76.37% |
| Dec 31, 2012 | -387.80% |
| Dec 31, 2011 | 115.83% |
| Sep 30, 2011 | -99.78% |
| Jun 30, 2011 | -27.21% |